trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Genomic Instability D042822 7 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Enteritis D004751 8 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Retinoblastoma D012175 12 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Brain Neoplasms D001932 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leishmaniasis D007896 19 associated lipids
Translocation, Genetic D014178 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Fibrosis D005355 23 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Breast Neoplasms D001943 24 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Glioblastoma D005909 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Zhang D et al. [Effects of trichostatin A on human lung cancer cell strains A549]. 2010 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:20450546
Ju ZH et al. [Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and apoptosis of ALDH1a2 gene in human bladder cancer cell lines]. 2010 Zhonghua Wai Ke Za Zhi pmid:20450613
Lu L et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. 2010 J. Immunol. pmid:20304828
Tokési N et al. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6. 2010 J. Biol. Chem. pmid:20308065
Zhou Q et al. TGFbeta mediated transition of corneal fibroblasts from a proinflammatory state to a profibrotic state through modulation of histone acetylation. 2010 J. Cell. Physiol. pmid:20232294
Chen WP et al. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. 2010 Mol. Biol. Rep. pmid:20237852
Urbinati G et al. Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy. 2010 Int J Pharm pmid:20603204
Sharma P et al. Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells. 2010 Mol. Cancer pmid:20609221
Mizutani H et al. Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. 2010 Cancer Sci. pmid:20624163
Yang J et al. A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. 2010 J. Biol. Chem. pmid:20630860
Wang XH et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. 2010 Am. J. Pathol. pmid:20581057
Terhune SS et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. 2010 PLoS Pathog. pmid:20585571
Luo W et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. 2010 Cancer Res. pmid:20587525
Xue K et al. Synchronous behaviors of CBP and acetylations of lysine 18 and lysine 23 on histone H3 during porcine oocyte first meiotic division. 2010 Mol. Reprod. Dev. pmid:20575085
Alamdari N et al. Sepsis and glucocorticoids upregulate p300 and downregulate HDAC6 expression and activity in skeletal muscle. 2010 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:20538901
Li J et al. Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. 2010 Autophagy pmid:20543569
Vamadevan AS et al. Regulation of Toll-like receptor 4-associated MD-2 in intestinal epithelial cells: a comprehensive analysis. 2010 Innate Immun pmid:19710105
Kaichi S et al. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. 2010 Cardiovasc. Res. pmid:20547733
Her S et al. Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors. 2010 J. Mol. Neurosci. pmid:19728174
Yoshikawa M et al. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. 2010 Eur. J. Pharmacol. pmid:20553909
Mousa SA et al. Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers. 2010 Cancer Lett. pmid:19733430
Russell SB et al. Epigenetically altered wound healing in keloid fibroblasts. 2010 J. Invest. Dermatol. pmid:20555348
Repouskou A et al. The circadian expression of c-MYC is modulated by the histone deacetylase inhibitor trichostatin A in synchronized murine neuroblastoma cells. 2010 Chronobiol. Int. pmid:20560708
Tessema M et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. 2010 Oncogene pmid:20562917
Kashiwagi Y et al. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. 2010 Invest. Ophthalmol. Vis. Sci. pmid:19737884
Kaimori A et al. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. 2010 Hepatology pmid:20564330
Dai X et al. Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide, a histone deacetylase inhibitor. 2010 J. Biol. Chem. pmid:20566633
Sudo H and Baas PW Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. 2010 J. Neurosci. pmid:20505088
Yoshizawa Y et al. Impaired active demethylation of the paternal genome in pronuclear-stage rat zygotes produced by in vitro fertilization or intracytoplasmic sperm injection. 2010 Mol. Reprod. Dev. pmid:19743475
Bui HT et al. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. 2010 Biol. Reprod. pmid:20505166
Kim IA et al. HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? 2010 J. Radiat. Res. pmid:20505264
Heier CR et al. Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. 2010 Hum. Mol. Genet. pmid:20693262
Hodges SJ et al. The effect of epigenetic therapy on congenital neurogenic bladders--a pilot study. 2010 Urology pmid:20138341
Bradner JE et al. Chemical phylogenetics of histone deacetylases. 2010 Nat. Chem. Biol. pmid:20139990
Gay S et al. Nucleotide supply, not local histone acetylation, sets replication origin usage in transcribed regions. 2010 EMBO Rep. pmid:20671737
Okada T et al. TWIST1 hypermethylation is observed frequently in colorectal tumors and its overexpression is associated with unfavorable outcomes in patients with colorectal cancer. 2010 Genes Chromosomes Cancer pmid:20140954
Shahabi S et al. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells. 2010 Gynecol. Oncol. pmid:20674962
Wessels I et al. Changes in chromatin structure and methylation of the human interleukin-1beta gene during monopoiesis. 2010 Immunology pmid:20141541
Zhang C et al. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. 2010 J. Hepatol. pmid:20675009
Swingler TE et al. MMP28 gene expression is regulated by Sp1 transcription factor acetylation. 2010 Biochem. J. pmid:20144149
Liu Z et al. Deacetylase inhibitor trichostatin A down-regulates Foxp3 expression and reduces CD4+CD25+ regulatory T cells. 2010 Biochem. Biophys. Res. Commun. pmid:20801101
Liu TY et al. EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis. 2010 Mol. Cancer pmid:20144199
Nam HJ et al. Clostridium difficile toxin A decreases acetylation of tubulin, leading to microtubule depolymerization through activation of histone deacetylase 6, and this mediates acute inflammation. 2010 J. Biol. Chem. pmid:20696758
Awe S and Renkawitz-Pohl R Histone H4 acetylation is essential to proceed from a histone- to a protamine-based chromatin structure in spermatid nuclei of Drosophila melanogaster. 2010 Syst Biol Reprod Med pmid:20170286
Jichan Nie SW et al. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. 2010 Reprod Sci pmid:20697142
Akiba Y et al. Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream. 2010 Biochem. Biophys. Res. Commun. pmid:20170631
Costa-Borges N et al. Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos. 2010 Cell Reprogram pmid:20698782
Angst E et al. Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. 2010 Pancreas pmid:20173668
Lee HS et al. Enhanced histone acetylation in somatic cells induced by a histone deacetylase inhibitor improved inter-generic cloned leopard cat blastocysts. 2010 Theriogenology pmid:20708232
Zhang L et al. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. 2010 World J Surg pmid:20177680
Tokoro M et al. Deposition of acetylated histones by RNAP II promoter clearance may occur at onset of zygotic gene activation in preimplantation mouse embryos. 2010 J. Reprod. Dev. pmid:20710121
Wu Y et al. Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A. 2010 Gynecol. Obstet. Invest. pmid:20130413
Torres J et al. Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas. 2010 Int. J. Oncol. pmid:20811720
Zhao J et al. Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos. 2010 Cell Reprogram pmid:20132015
Chuang C et al. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. 2010 J. Proteome Res. pmid:20812760
Martinez-Diaz MA et al. Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. 2010 Cell Reprogram pmid:20132016
Yang F et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. 2010 BMC Plant Biol. pmid:20718950
Host L et al. Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique. 2010 J. Neurochem. pmid:20132486
Wu Y et al. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation. 2010 BMC Cancer pmid:20132554
Kim TH et al. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice. 2010 Int. Immunopharmacol. pmid:20728595
Bracha AL et al. Carbon metabolism-mediated myogenic differentiation. 2010 Nat. Chem. Biol. pmid:20081855
Pan L et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. 2010 FEBS J. pmid:20089040
Bayles R et al. Histone modifications regulate the norepinephrine transporter gene. 2010 Cell Cycle pmid:21088495
Wang J et al. Effect of EGF-induced HDAC6 activation on corneal epithelial wound healing. 2010 Invest. Ophthalmol. Vis. Sci. pmid:20089874
Hutt DM et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. 2010 Nat. Chem. Biol. pmid:19966789
Islam NM et al. Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length. 2010 Bioorg. Med. Chem. Lett. pmid:20045316
Benny Klimek ME et al. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. 2010 Biochem. Biophys. Res. Commun. pmid:20036643
Peng CY et al. Growth-inhibiting effects of arsenic trioxide plus epigenetic therapeutic agents on leukemia cell lines. 2010 Leuk. Lymphoma pmid:20038232
Li RJ et al. Down-regulation of mitochondrial ATPase by hypermethylation mechanism in chronic myeloid leukemia is associated with multidrug resistance. 2010 Ann. Oncol. pmid:20038517
Nordén R et al. Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. 2010 Arch. Virol. pmid:20039087
Emonds E et al. Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. 2010 World J. Gastroenterol. pmid:20419833
Bao BY et al. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206692
Meng CF et al. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. 2010 Cancer Invest. pmid:19857042
Sayan BS et al. Induction of TAp63 by histone deacetylase inhibitors. 2010 Biochem. Biophys. Res. Commun. pmid:20043870
Tian F et al. NMDA receptor activation induces differential epigenetic modification of Bdnf promoters in hippocampal neurons. 2010 Amino Acids pmid:19565326
Wang X et al. Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells. 2010 Blood pmid:20858855
Gushchina SV et al. [Cellular aspects of regulation of nuclear factor kappaB (NF-kappabeta) transcriptional activity in sensory neurons in vitro]. 2010 Morfologiia pmid:20960709
Liu YL et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. 2010 Autophagy pmid:20962572
McKenzie L et al. p53-dependent repression of polo-like kinase-1 (PLK1). 2010 Cell Cycle pmid:20962589
Mittal MK et al. Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. 2010 Mol. Biol. Rep. pmid:19277896
Pan L et al. HDAC4 inhibits the transcriptional activation of mda-7/IL-24 induced by Sp1. 2010 Cell. Mol. Immunol. pmid:20383178
Kim HB et al. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. 2010 Mol. Cell. Biol. pmid:20385772
MacTavish H et al. Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors. 2010 PLoS ONE pmid:21283510
Varma A and Kwon-Chung KJ Heteroresistance of Cryptococcus gattii to fluconazole. 2010 Antimicrob. Agents Chemother. pmid:20385871
Yang H et al. Histone modification-mediated CYP2E1 gene expression and apoptosis of HepG2 cells. 2010 Exp. Biol. Med. (Maywood) pmid:20404016
Lei L et al. Epigenetic repression of SATB1 by polycomb group protein EZH2 in epithelial cells. 2010 Chin. Med. Sci. J. pmid:21232178
Wang G et al. The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice. 2010 Regen Med pmid:20210581
Obier N et al. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival. 2010 Cytotherapy pmid:20210674
Krishnan M et al. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. 2010 Oncogene pmid:19881542
Trtková K et al. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. 2010 Cancer Biomark pmid:21178266
Ninios YP et al. Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells. 2010 Apoptosis pmid:19882353
Spin JM et al. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. 2010 PLoS ONE pmid:21179216
Wang N and Tilly JL Epigenetic status determines germ cell meiotic commitment in embryonic and postnatal mammalian gonads. 2010 Cell Cycle pmid:20009537
Zhao H et al. New biomarkers probing depth of cell senescence assessed by laser scanning cytometry. 2010 Cytometry A pmid:20939035
Wang L et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. 2010 Neuropsychopharmacology pmid:20010550
Fernandez G and Zeichner SL Cell line-dependent variability in HIV activation employing DNMT inhibitors. 2010 Virol. J. pmid:20942961
Lee CS et al. Casein kinase 2 inhibition differentially modulates apoptotic effect of trichostatin A against epithelial ovarian carcinoma cell lines. 2010 Mol. Cell. Biochem. pmid:20020183
Ibanez de Caceres I et al. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. 2010 Oncogene pmid:20023704
Kuribayashi T et al. Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation. 2010 Int. J. Mol. Med. pmid:19956898
Hui KF and Chiang AK Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. 2010 Int. J. Cancer pmid:19816947